Strata Oncology Announces Addition of Gilead as Strata PATH Trial Collaborator

Gilead to supply TRODELVY for prospective, pan-tumor trial ANN ARBOR, Mich., Jan. 18, 2023 /PRNewswire/ -- Strata Oncology, Inc. a next-generation precision oncology company enabling smarter and earlier cancer treatment, today announced that Gilead Sciences, Inc. has agreed to collaborate...

Click to view original post